T1	p 23 39	asthma in adults
T2	p 230 260	31 adult asthmatic patients in
T3	i 46 87	sodium cromoglycate pressurized aerosol :
T4	i 122 179	Sodium cromoglycate formulated as a pressurized aerosol (
T5	i 185 212	4-times daily ) and placebo
T6	i 309 330	. Sodium cromoglycate
T7	i 347 354	placebo
T8	i 769 790	sodium cromoglycate .
T9	i 811 869	bronchodilators ( theophylline and aerosol beta-stimulants
T10	i 933 962	sodium cromoglycate treatment
T11	i 975 984	placebo .
T12	i 1053 1105	sodium cromoglycate delivered by pressurized aerosol
T13	i 1136 1145	placebo ,
T14	i 1224 1250	concomitant bronchodilator
T15	o 368 385	breathlessness at
T16	o 415 441	breathlessness on exertion
T17	o 471 487	quality of sleep
T18	o 538 577	morning peak expiratory flow rate value
T19	o 694 702	opinions
T20	o 988 1000	side-effects
T21	o 1168 1186	asthmatic symptoms
T22	o 1214 1220	amount